Drugs / A-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00434473 | Dec 2006 → Aug 2009 | acute chest syndrome, sickle cell disease | Anthera Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00434473 ↗ |
| Known as | Varespladib | “Varespladib Infusion [A-001]” NCT00434473 ↗ |